ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links5 made here, not in the record7 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06837792Trastuzumab Deruxtecan vsEndocrine Therapy inLow-HER2 HR+ AdvancedBreast CancerYonsei UniversityPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSBreast NeoplasmsNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSTrastuzumab deruxtecanMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTestedFulvestrantMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · ComparatorComparatorCapivasertibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · ComparatorComparatorAlpelisibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · ComparatorComparatorExemestaneMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · ComparatorComparatorTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Trastuzumab deruxtecan

Made here1 judgment on this link
NCT06837792gives it, found by reading the recordTrastuzumab deruxtecanDefined by Claude Opus 5.5Nov 3, 2026, 6:51 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2TrastuzumabClaude Opus 5.5Not givenCurrent
Nov 3Trastuzumab deruxtecanmade hereClaude Opus 5.5TestedCurrent
Nov 3Fulvestrantmade hereClaude Opus 5.5ComparatorCurrent
Nov 3Capivasertibmade hereClaude Opus 5.5ComparatorCurrent
Nov 3Alpelisibmade hereClaude Opus 5.5ComparatorCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 10Exemestanemade hereClaude Opus 5.5ComparatorCurrent
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.